No signal from GSSG molecule was observed during measurements
From a recent Reuters article , ResMed CEO Michael Farrell said he thought weight-loss drugs wouldnt have a major impact on the companys future salesEven so, ResMeds stock has since lost about a third of its value
Here's everything happening in the GLP-1 universe country by country & drug by drug Everything about GLP Market Published February 2026 12 min read Covers 17 countries, 30+ companies, and the next decade of the most competitive pharmaceutical race in history If youve heard of Ozempic, Wegovy, or Mounjaro, you already know the pitch: injectable drugs that help people lose dramatic amounts of weight, control blood sugar, and maybe prevent heart disease along the way
Additional Considerations A few foundational notes, too
Ideal for athletes and fitness enthusiasts looking to optimize performance
In 2024, the home care settings and fitness/weight management facilities accounted for the largest share in the global GLP-1 agonists market